Methylphenidate
- Generic Name
- Methylphenidate
- Brand Names
- Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 113-45-1
- Unique Ingredient Identifier
- 207ZZ9QZ49
- Background
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve ...
- Indication
Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
The Effects of Methylphenidate on Energy Intake and Energy Expenditure
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- Children's Hospital of Eastern Ontario
- Target Recruit Count
- 40
- Registration Number
- NCT02754258
- Locations
- 🇨🇦
Children's Hospital Of Eastern Ontario Research Institute, Ottawa, Ontario, Canada
🇨🇦University of Ottawa, Ottawa, Ontario, Canada
Concerta (Methylphenidate) -To-Generic Switch Study
- Conditions
- Interventions
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2017-02-13
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 1464
- Registration Number
- NCT02730572
Methylphenidate (Ritalin®) Effect During Exposure to Exercise and Heat Stress in ADD/ADHD Treated Patients
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2016-03-10
- Lead Sponsor
- Sheba Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02704546
- Locations
- 🇮🇱
Sheba medical center, Tel-Hashomer, Ramat- Gan, Israel
Methylphenidate-Duloxetine Combinations for Cocaine Dependence
- Conditions
- Interventions
- First Posted Date
- 2016-03-07
- Last Posted Date
- 2018-06-26
- Lead Sponsor
- University of Kentucky
- Target Recruit Count
- 13
- Registration Number
- NCT02700711
- Locations
- 🇺🇸
University of Kentucky Medical Center, Lexington, Kentucky, United States
Effect of Pycnogenol® on ADHD
- Conditions
- Interventions
- First Posted Date
- 2016-03-07
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Nina Hermans
- Target Recruit Count
- 88
- Registration Number
- NCT02700685
- Locations
- 🇧🇪
University Hospital Antwerp, Edegem, Belgium
🇧🇪University Hospital Ghent, Ghent, Belgium
🇧🇪Universitaire Kinder- en Jeugdpsychiatrie, Borgerhout, Belgium
The Effect of Methylphenidate on Primary Enuresis in Children With Attention Deficit Hyperactivity Disorder
- First Posted Date
- 2016-03-04
- Last Posted Date
- 2016-09-16
- Lead Sponsor
- Meir Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT02699528
- Locations
- 🇮🇱
Meir Medical Center, Kfar Saba, Israel
Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
- Conditions
- Interventions
- First Posted Date
- 2016-02-05
- Last Posted Date
- 2018-09-12
- Lead Sponsor
- Seattle Children's Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT02675400
- Locations
- 🇺🇸
Seattle Children's, Seattle, Washington, United States
Evaluation of Use of Brain Activity Monitoring Dynamics in ADHD
- Conditions
- Interventions
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2017-06-16
- Lead Sponsor
- Brainmarc Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT02625805
- Locations
- 🇮🇱
Shalvata Hospital, Hod Hasharon, Israel
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
- Conditions
- Interventions
- First Posted Date
- 2015-12-07
- Last Posted Date
- 2015-12-07
- Lead Sponsor
- Seoul National University Childrens Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT02623114
- Locations
- 🇰🇷
Seoul National University Children's Hospital, Seoul, Korea, Republic of
Intervention for Teens With ADHD and Substance Use
- First Posted Date
- 2015-07-20
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Florida International University
- Target Recruit Count
- 158
- Registration Number
- NCT02502799
- Locations
- 🇺🇸
Florida International University Center for Children and Families, Miami, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.